搜索临床试验以:SNP-612 剂量 2
总计8842个结果
-
National Institute of Allergy and Infectious Diseases...完全的
-
Jiangsu Kanion Pharmaceutical Co., LtdShanghai Mental Health Center尚未招聘
-
Sarepta Therapeutics, Inc.完全的
-
Sarepta Therapeutics, Inc.Hoffmann-La Roche邀请报名
-
National Institute of Allergy and Infectious Diseases...Gritstone bio, Inc.完全的
-
Shanghai Keku Medical Technology Co., Ltd.Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University尚未招聘
-
University Hospital, Basel, SwitzerlandSwiss National Science Foundation完全的
-
University of VirginiaNational Institute for Biomedical Imaging and Bioengineering (NIBIB)未知
-
Haukeland University HospitalNorwegian Foundation for Health and Rehabilitation; Foundation to Promote Research into Functional...完全的
-
Petrovsky National Research Centre of Surgery完全的
-
University of Texas at Austin尚未招聘
-
Beijing Anzhen HospitalThe George Institute for Global Health, Australia; The George Institute for Global Health, China 和其他合作者招聘中
-
Gerencia de Atención Primaria, MadridInstituto de Salud Carlos III完全的
-
Mayo ClinicNational Cancer Institute (NCI)招聘中复发性 B 细胞非霍奇金淋巴瘤 | 复发性原发性纵隔(胸腺)大 B 细胞淋巴瘤 | 伴有 MYC、BCL2 和 BCL6 重排的复发性高级别 B 细胞淋巴瘤 | 具有 MYC、BCL2 和 BCL6 重排的难治性高级 B 细胞淋巴瘤 | 复发性弥漫性大 B 细胞淋巴瘤,未另行说明 | 伴有 MYC 和 BCL2 或 BCL6 重排的复发性高级别 B 细胞淋巴瘤 | 难治性弥漫性大 B 细胞淋巴瘤,未另行说明 | 具有 MYC 和 BCL2 或 BCL6 重排的难治性高级 B 细胞淋巴瘤 | 复发性高级 B 细胞淋巴瘤 | 难治性高级 B 细胞淋巴瘤 | 复发性 3b 级滤泡性淋巴瘤 | 难治性 3b 级滤泡性淋巴瘤 | 复发性血管内大 B 细胞淋巴瘤 | 复发性 T 细胞/富含组织细胞的大 B 细胞淋巴瘤 及其他条件美国
-
MRC/UVRI and LSHTM Uganda Research Unit招聘中
-
Pneumacare LtdCambridge University Hospitals NHS Foundation Trust; University of Cambridge完全的
-
Aga Khan UniversityBill and Melinda Gates Foundation; International Food Policy Research Institute招聘中
-
TakedaShire; Takeda Development Center Americas, Inc.招聘中
-
Tor A. StrandThrasher Research Fund; Society for Essential Health Action and Training, New Delhi, India完全的
-
Solutex GC S.L.OAFI Foundation (Osteoarthritis Foundation International)完全的
-
Nantes University Hospital招聘中
-
Sarepta Therapeutics, Inc.完全的
-
OrputecMedical University of Graz; Joanneum Research Forschungsgesellschaft mbH终止
-
Assistance Publique - Hôpitaux de ParisBiosite; Dräger Médical S.A完全的